跳至主要内容
临床试验/NL-OMON26266
NL-OMON26266已完成不适用

Development of cellular immune response after infant pneumococcal conjugate vaccinations.

etherlands Vaccine Institute0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. The children have to be of normal health (same health criteria apply as used in well-baby clinics when a child receives a vaccination, e.g. also children with small increases in temperature or cold are seen as children with normal health)
  • 2. They have to be willing and able to allow their child to participate in the trial according to the described procedures

排除标准

  • 1. Previous vaccinations with Prevenar® using a schedule that differs from the Dutch 3+1 schedule
  • 2. Previous vaccinations with other pneumoccocal vaccines

研究者

发起方
etherlands Vaccine Institute

相似试验